0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month—Diagnosis FREE

[+] Author Affiliations

Section Editor: Samir S. Shah, MD

More Author Information
Arch Pediatr Adolesc Med. 2010;164(4):388. doi:10.1001/archpediatrics.2010.39-b.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: KAPOSIFORM HEMANGIOENDOTHELIOMA WITH KASABACH-MERRITT PHENOMENON

Kaposiform hemangioendothelioma (KHE) is a locally aggressive rare vascular tumor that was described in 1979 by Pearl and Mathews1and further characterized and named kaposiform hemangioendotheliomaby Zukerberg et al2in 1993.

The clinical features of KHE are quite distinguishable from other pediatric endothelial tumors. Kaposiform hemangioendothelioma is evident at birth or appears shortly after in the early infantile period. Rarely, KHE develops in adults.3Unlike the more common infantile hemangioma that has a definite predilection to affect female infants, KHE has no significant sex predilection.35

The histological features of KHE are characterized by a predominant Kaposi sarcoma–like, fascicular spindle cell growth pattern of epithelial cells, infiltrating nodules with slitlike or crescentic vessels that are poorly canalized.2Clinically, KHE presents with an infiltrative ecchymotic induration of the skin and underlying soft tissue. The lesion is solitary with predilection to the trunk, extremities, retroperitoneum, and head and neck.6Kaposiform hemangioendothelioma has a mortality rate of approximately 24% related to the coagulopathy or complication of local tumor infiltration.3

Severe thrombocytopenia (Kasabach-Merritt phenomenon) is a major cause of morbidity and mortality and is encountered in the majority of patients. Kasabach-Merritt phenomenon can also be associated with hypofibrinogenemia/fibrinolysis and anemia with normal or minimally elevated prothrombin and activated partial thromboplastin times.7Low-flow vascular anomalies (such as venous and extensive lymphatic malformations) may also cause consumptive coagulopathy characterized by elevated D-dimer level, low fibrinogen level, and normal to mildly decreased platelet count.3The combination of clinical, laboratory, and imaging findings in KHE is usually sufficient to establish the diagnosis. The patient presented herein was considered to have KHE with Kasabach-Merritt phenomenon on the basis of the classic cutaneous findings, anatomical location, age at presentation, and severe thrombocytopenia.

Chemotherapy, including the use of vincristine, cyclophosphamide, corticosteroids, interferon alfa-2a or -2b, and other agents, has been reported to be effective in Kasabach-Merritt phenomenon. However, no single treatment has given consistently reproducible results (defined as normalization of the platelet count and shrinkage of the tumor).4

Return to Quiz Case.

Correspondence:Ahmad I. Alomari, MD, MSc, Division of Vascular and Interventional Radiology, Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115 (ahmad.alomari@childrens.harvard.edu).

Accepted for Publication:December 29, 2009.

Author Contributions:Study concept and design: A. K. Alomari and A. I. Alomari. Acquisition of data: A. K. Alomari and A. I. Alomari. Analysis and interpretation of data: A. K. Alomari and A. I. Alomari. Drafting of the manuscript: A. K. Alomari and A. I. Alomari. Critical revision of the manuscript for important intellectual content: A. K. Alomari and A. I. Alomari. Study supervision: A. K. Alomari and A. I. Alomari.

Financial Disclosure:None reported.

Pearl  GSMathews  WH Congenital retroperitoneal hemangioendothelioma with Kasabach-Merritt syndrome. South Med J 1979;72 (2) 239- 240
PubMed Link to Article
Zukerberg  LRNickoloff  BJWeiss  SW Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17 (4) 321- 328
PubMed Link to Article
Sarkar  MMulliken  JBKozakewich  HPRobertson  RLBurrows  PE Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100 (6) 1377- 1386
PubMed Link to Article
Enjolras  OMulliken  JBWassef  M  et al.  Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000;42 (2, pt 1) 225- 235
PubMed Link to Article
Lyons  LLNorth  PEMac-Moune Lai  FStoler  MHFolpe  ALWeiss  SW Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28 (5) 559- 568
PubMed Link to Article
Konez  OBurrows  PE Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 2002;10 (2) 363- 388
PubMed Link to Article
Mulliken  JBAnupindi  SEzekowitz  RAMihm  MC  Jr Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 13-2004: a newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med 2004;350 (17) 1764- 1775
PubMed Link to Article

Figures

Tables

References

Pearl  GSMathews  WH Congenital retroperitoneal hemangioendothelioma with Kasabach-Merritt syndrome. South Med J 1979;72 (2) 239- 240
PubMed Link to Article
Zukerberg  LRNickoloff  BJWeiss  SW Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17 (4) 321- 328
PubMed Link to Article
Sarkar  MMulliken  JBKozakewich  HPRobertson  RLBurrows  PE Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100 (6) 1377- 1386
PubMed Link to Article
Enjolras  OMulliken  JBWassef  M  et al.  Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000;42 (2, pt 1) 225- 235
PubMed Link to Article
Lyons  LLNorth  PEMac-Moune Lai  FStoler  MHFolpe  ALWeiss  SW Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28 (5) 559- 568
PubMed Link to Article
Konez  OBurrows  PE Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 2002;10 (2) 363- 388
PubMed Link to Article
Mulliken  JBAnupindi  SEzekowitz  RAMihm  MC  Jr Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 13-2004: a newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med 2004;350 (17) 1764- 1775
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles